Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine

por Albany, Costantine, Hever-Jardine, Mary P., von Herrmann, Katherine M., Yim, Christina Y., Tam, Janice, Warzecha, Joshua M., Shin, Leah, Bock, Sarah E., Curran, Brian S., Chaudhry, Aneeq S., Kim, Fred, Sandusky, George E., Taverna, Pietro, Freemantle, Sarah J., Christensen, Brock C., Einhorn, Lawrence H., Spinella, Michael J.
Publicado 2016